Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $681,232 - $937,715
-163,365 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$5.28 - $9.64 $3,696 - $6,748
-700 Reduced 0.43%
163,365 $863,000
Q4 2020

Feb 16, 2021

SELL
$5.75 - $7.13 $228,275 - $283,061
-39,700 Reduced 19.48%
164,065 $1.07 Million
Q3 2020

Nov 16, 2020

SELL
$4.9 - $7.12 $48,823 - $70,943
-9,964 Reduced 4.66%
203,765 $1.25 Million
Q2 2020

Aug 12, 2020

SELL
$6.43 - $9.86 $162,865 - $249,743
-25,329 Reduced 10.6%
213,729 $1.55 Million
Q1 2020

May 12, 2020

SELL
$6.36 - $10.05 $2.19 Million - $3.46 Million
-344,473 Reduced 59.03%
239,058 $1.66 Million
Q4 2019

Feb 11, 2020

SELL
$8.49 - $12.81 $182,093 - $274,748
-21,448 Reduced 3.55%
583,531 $5.15 Million
Q3 2019

Nov 13, 2019

SELL
$5.58 - $14.47 $679,777 - $1.76 Million
-121,824 Reduced 16.76%
604,979 $6.78 Million
Q2 2019

Aug 08, 2019

BUY
$5.22 - $9.08 $197,577 - $343,678
37,850 Added 5.49%
726,803 $0
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $2.4 Million - $4.4 Million
448,175 Added 186.14%
688,953 $0
Q4 2018

Feb 07, 2019

BUY
$3.43 - $6.19 $570,649 - $1.03 Million
166,370 Added 223.59%
240,778 $1.19 Million
Q3 2018

Nov 07, 2018

BUY
$4.75 - $14.5 $19,427 - $59,305
4,090 Added 5.82%
74,408 $0
Q2 2018

Aug 13, 2018

BUY
$13.3 - $17.45 $261,611 - $343,241
19,670 Added 38.84%
70,318 $0
Q1 2018

May 04, 2018

BUY
$14.7 - $24.95 $18,963 - $32,185
1,290 Added 2.61%
50,648 $0
Q4 2017

Feb 13, 2018

BUY
$19.9 - $29.25 $8,955 - $13,162
450 Added 0.92%
49,358 $1.15 Million
Q3 2017

Nov 02, 2017

BUY
$15.1 - $19.25 $738,510 - $941,479
48,908
48,908 $902,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.